PROCYON
Procyon 's P3000 Pro is the first pupillometer seeking FDA labelling for Glaucoma screening. Feasibility studies under the auspices of Moorfields Eye Hospital demonstrated a 87% sensitivity and specificity for Glaucoma, a significant statistical improvement in accuracy over current technology. The Procyon management team has extensive experience in ophthalmic devices - research/development, FDA trials, Medicare, marketing/sales.
PROCYON
Industry:
Innovation Management
Address:
London, England, United Kingdom
Country:
United Kingdom
Status:
Active
Similar Organizations
OcellO
OcellO is an innovative biotech company.
PistonPower
PistonPower is an innovative technology company.
Prowise
Prowise is a dynamic and innovative Dutch company .